Artificial Intelligence Program to Predict p53 Mutations in Ulcerative Colitis-Associated Cancer or Dysplasia.
Tatsuki NoguchiTakumi AndoShigenobu EmotoHiroaki NozawaKazushige KawaiKazuhito SasakiKoji MuronoJunko KishikawaHiroaki IshiYuichiro YokoyamaShinya AbeYuzo NagaiHiroyuki AnzaiHirofumi SonodaKeisuke HataTakeshi SasakiSoichiro IshiharaPublished in: Inflammatory bowel diseases (2022)
Our trained CNN can be used as a reasonable alternative to conventional p53 immunohistochemical staining in the pathological diagnosis of colitis-associated neoplasia, which is accurate, saves time, and is cost-effective.